COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication
This study has been completed.
Information provided by (Responsible Party):
First received: January 10, 2011
Last updated: September 10, 2013
Last verified: September 2013
The aim of this multi-centre survey is to assess treatment adherence and quality of life in a Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled essential hypertension being on antihypertensive treatment for at least 6 months.
||Time Perspective: Prospective
||COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication
Primary Outcome Measures:
Secondary Outcome Measures:
- Health Related Quality of Life (MINICHAL Score) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
To compare and identify changes in the quality of life before and after anti-hypertensive treatment.
- Type of pharmacological treatments [ Time Frame: 6 months ] [ Designated as safety issue: No ]
To identify the pharmacological treatments used by physicians in Jordan and Lebanon to treat patients newly diagnosed or with uncontrolled hypertension.
- Factors affecting adherence to treatment [ Time Frame: 6 months ] [ Designated as safety issue: No ]
To identify associated factors that may alter adherence to anti-hypertensive treatment.
- Compliance rate by antihypertensive regimen used [ Time Frame: 6 months ] [ Designated as safety issue: No ]
To compare treatment rate for different antihypertensive regimen used
- Percentage of controlled patients [ Time Frame: 6 months ] [ Designated as safety issue: No ]
To identify the percentage of patients reaching their target blood pressure according to the JNCVII criteria.
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||September 2012 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||21 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
multi-centre survey of patients
- Patients older than 21 years of age
- Patients newly diagnosis with essential hypertension or with hypertension that is uncontrolled after being under the same antihypertensive treatment for at least 6 months (based on the criteria established by the Joint National Committee VII)
- Patients capable of providing an informed consent
- Patients with secondary hypertension
- Pregnant women or nursing mothers
- Patients with acute illnesses or psychiatric diagnosis
No Contacts or Locations Provided
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 10, 2011
||September 10, 2013
||Jordan: Ethical Committee
Lebanon: Institutional Review Board
Keywords provided by AstraZeneca:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 23, 2014